// STARTUP COMPARISON
Badi vs Clínica Sim
Badi failed in 2022 due to Bad Timing. Clínica Sim failed in 2023 due to Unit Economics. Different causes, different sectors, different eras — but the same simulation outcome.
| METRIC | 🔥 Badi | 🔥 Clínica Sim |
|---|---|---|
| Sector | Proptech | Healthtech |
| Country | Spain | Brazil |
| Founded | 2015 | 2019 |
| Died | 2022 | 2023 |
| Raised | $30M | $40M |
| Peak | $30M raised | $150M valuation (2022) |
| Primary Cause | Bad Timing | Unit Economics |
// WHY EACH FAILED
🔥 Badi
Bad Timing
Badi built a Tinder-style matching app for room rentals in urban markets (Barcelona, Madrid, London, NYC). The model depended entirely on urban density — young professionals needing affordable shared housing near work. COVID emptied city centers as remote work spread. Demand for urban room rentals collapsed in 2020-2021. By the time urban density recovered, cheaper competitors (Idealista, Fotocasa, SpareRoom) had consolidated the market. Badi shut down its platform in 2022.
// LESSON
Marketplaces that depend on urban density have zero pandemic resilience. Badi needed people in cities and needed them to be price-constrained. Remote work broke both assumptions simultaneously.
Marketplaces that depend on urban density have zero pandemic resilience. Badi needed people in cities and needed them to be price-constrained. Remote work broke both assumptions simultaneously.
🔥 Clínica Sim
Unit Economics
Clínica Sim was a Brazilian telehealth platform offering $5 video consultations, subsidized by partnerships with health insurance plans (operadoras). The business model required health plan partners to pay a per-consultation fee, but Brazilian operadoras saw telehealth as a cost-saving tool and negotiated fees down from $12 to $4 per consultation over 18 months. With unit economics inverted — $5 consultation cost vs. $4 plan revenue — and B2C patients unwilling to pay $10+, the company raised a bridge in 2022 and shut in 2023.
// LESSON
Never build a B2B2C model where the B decides the price and the C is too price-sensitive to cover the shortfall. Health insurance companies have pricing power and procurement teams — startups do not.
Never build a B2B2C model where the B decides the price and the C is too price-sensitive to cover the shortfall. Health insurance companies have pricing power and procurement teams — startups do not.
// EXPLORE FURTHER